NCT02292914

Brief Summary

The robot-assisted surgery allows three-dimensional view, detailed access of small structures, depth perception and articulated movements with wide latitude. Thinking about the inclusion of this branch of surgical outcome ICESP encouraged the training of their doctors and other health professionals , and has three tutors in the area of robot- assisted laparoscopic surgery , and various medical clinical staff , already trained , and already perform the procedure in other centers . The da Vinci ® Surgical System ( only existing in the World market) , consisting of one or two consoles for the surgeon and a tutor if necessary was adopted. Ergonomically designed, a stand next to the patient , with four interactive robotic arms , one of them , a vision system for high performance and the other three for exclusive EndoWrist ® instruments . Driven by the latest robotic technology , computer programs , frictionless transmission of manual controls , movements in scale and filtered made by the surgeon in the da Vinci ® System console are translated into precise movements of the instruments EndoWrist ® For surgeons , the da Vinci ® System offers superior 3D viewing with larger surgical precision ergonomic comfort and dexterity . For hospitals , the da Vinci ® Surgical System enables clinical and economic benefits of minimally invasive surgery are applied to a broader base of patients cirúrgicos.The main objective is to evaluate the safety and effectiveness of robotic surgery in the surgical treatment of cancer in operations below, as their specialties : Digestive , Urology , Gynecology , Head and Neck and Thorax . This is a prospective study lasting 36 months , where 1120 patients with surgical diseases in programming for the following operations will be studied : transthoracic esophagectomy ; subtotal gastrectomy with lymphadenectomy ; partial pancreatectomy ; resection of the rectum ; prostatectomy ; cystectomy ; partial nephrectomy ; hysterectomy with or without pelvic and paraaortic lymphadenectomy ; resection of malignant tumors of the mouth and orofaringolaringe and lung lobectomy . Patients will come from the outpatient services of the Institute of Cancer of São Paulo - ICESP

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,120

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 18, 2014

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2020

Completed
Last Updated

August 8, 2019

Status Verified

August 1, 2019

Enrollment Period

6.3 years

First QC Date

September 3, 2014

Last Update Submit

August 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Complications

    The postoperative complications will be mesured by clavien-dindo scale

    30 days

Secondary Outcomes (1)

  • ICU and hospital length of stay

    2 days

Other Outcomes (5)

  • Surgical time

    1 day

  • Intraoperative complications

    1 day

  • quality of life of cancer patients

    36 months

  • +2 more other outcomes

Study Arms (2)

Robot-Assisted Surgery

EXPERIMENTAL

patients undergoing robot assisted surgery for the treatment of cancer

Procedure: Robot-assisted surgery

Conventional Surgery

ACTIVE COMPARATOR

patients undergoing conventional surgery for the treatment of cancer

Procedure: Conventional Surgery

Interventions

Robot-assisted esophagectomy; Robot-assisted subtotal gastrectomy; Robot-assisted pancreatectomy;Robot-assisted rectal resection; Robot-assisted radical cistectomy;Robot-assisted prostatectomy;Robot-assisted Partial Nephrectomy; Robot-assisted hysterectomy;Robot-assisted Resection of malignant tumors of the mouth and orofaringolaringe; Robot-assisted lung lobectomy

Robot-Assisted Surgery

Thoracoscopic Esophagectomy; Open rectal resection and rectal laparoscopy resection; Open radical cistectomy; Open prostatectomy; Open Partial Nephrectomy; Laparoscopic hysterectomy; Laparoscopic lung lobectomy

Conventional Surgery

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients eligible for robotic-assisted surgery

You may not qualify if:

  • Pregnant patients
  • Patients with decompensated systemic diseases
  • Patients who were unfit for general anesthesia
  • Patients without an indication for surgical treatment of cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto do Câncer de São Paulo - ICESP

São Paulo, Brazil

RECRUITING

Related Publications (4)

  • Abdalla RZ, Nahas WC, Cecconello I, Ribeiro U Jr. Prospective study of a structured robotic surgery training program in a public cancer hospital in Brazil. J Robot Surg. 2025 Oct 16;19(1):695. doi: 10.1007/s11701-025-02881-6.

  • Nahas WC, Rodrigues GJ, Rodrigues Goncalves FA, Sawczyn GV, Barros GG, Cardili L, Guglielmetti GB, Fazoli AJC, Cordeiro MD, Cassao VDA, Chade DC, Neves De Oliveira LC, Murta CB, Pontes Junior J, Trindade EM, Bastos DA, Sarkis AS, Mitre AI, Trinh QD, Coelho RF. Perioperative, Oncological, and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial. J Urol. 2024 Jul;212(1):32-40. doi: 10.1097/JU.0000000000003967. Epub 2024 May 9.

  • Ribeiro U Jr, Dias AR, Ramos MFKP, Yagi OK, Oliveira RJ, Pereira MA, Abdalla RZ, Zilberstein B, Nahas SC, Cecconello I. Short-Term Surgical Outcomes of Robotic Gastrectomy Compared to Open Gastrectomy for Patients with Gastric Cancer: a Randomized Trial. J Gastrointest Surg. 2022 Dec;26(12):2477-2485. doi: 10.1007/s11605-022-05448-0. Epub 2022 Sep 20.

  • Terra RM, Araujo PHXN, Lauricella LL, Campos JRM, Trindade JRM, Pego-Fernandes PM. A Brazilian randomized study: Robotic-Assisted vs. Video-assisted lung lobectomy Outcomes (BRAVO trial). J Bras Pneumol. 2022 Jul 8;48(4):e20210464. doi: 10.36416/1806-3756/e20210464. eCollection 2022.

MeSH Terms

Conditions

Esophageal NeoplasmsStomach NeoplasmsPancreatic NeoplasmsRectal NeoplasmsUrinary Bladder NeoplasmsProstatic NeoplasmsKidney NeoplasmsUterine NeoplasmsHead and Neck NeoplasmsLung Neoplasms

Interventions

Robotic Surgical Procedures

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesStomach DiseasesEndocrine Gland NeoplasmsPancreatic DiseasesEndocrine System DiseasesColorectal NeoplasmsIntestinal NeoplasmsIntestinal DiseasesRectal DiseasesUrologic NeoplasmsUrogenital NeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital DiseasesGenital Neoplasms, MaleGenital Diseases, MaleGenital DiseasesProstatic DiseasesKidney DiseasesGenital Neoplasms, FemaleUterine DiseasesGenital Diseases, FemaleRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Surgery, Computer-AssistedSurgical Procedures, OperativeRoboticsAutomationTechnologyTechnology, Industry, and Agriculture

Study Officials

  • Ivan Cecconello, MD

    Faculdade de Medicina da USP

    PRINCIPAL INVESTIGATOR
  • Ulysses Ribeiro-Junior, MD

    Faculdade de Medicina da USP

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ivan Cecconello, MD

CONTACT

Ulysses Ribeiro-Junior, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2014

First Posted

November 18, 2014

Study Start

March 10, 2014

Primary Completion

July 10, 2020

Study Completion

July 10, 2020

Last Updated

August 8, 2019

Record last verified: 2019-08

Locations